Obermatt
See Similar Stocks →

InspireMD

NAQ:NSPR · US45779A8466
Health Care Equipment & SuppliesSmall

360

25
EV / EBIT100
Price / Owner Earnings63
Owner Earnings Yield1
Dividend Yield1
Price/Sales54
Price/Book39
Return on Capital1
Cash Return on Capital1
Return on Equity6
Profit margins12
Accruals3
Owner Earnings Margin4
Sales growth51
Profit growth37
Reinvestment87
Price momentum6
Debt load84
Refinancing22
Debt Payback1
Liquidity97
Analyst ratings27
Expectations trend50
Market mood38
Value Creation8/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

InspireMD clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Employees105
Websiteinspiremd.com/en
ISINUS45779A8466
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
NeurologyCardiovascularHealth DiagnosticsCentral Nervous SystemBiomedical Engineering

Description

InspireMD, Inc., a medical device company, specializes in the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions. The company’s portfolio includes two commercial products based on…

Analysis

Weak and unloved

InspireMD, Inc. scores below average on quality and is priced accordingly, a low-conviction position in either direction.

Valuation data is not available for this company.

Growth is moderate; the safety picture is adequate. The company scores 8/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
54
2026

All-time high

54

Jun 2026

All-time low

21

Mar 2026

Average rank

38

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
54
—
—
—
Price/Earnings
50
—
—
—
Price/Book
39
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
79
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare InspireMD with its peers
Cardiol Therapeutics
TOR:CRDL
81
CountryCanada
IndustryPharmaceuticals
SizeX-Small
Full Stock Analysis →
Rigel Pharmaceuticals
NSQ:RIGL
66
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Natera
NSQ:NTRA
39
CountryUSA
IndustryBiotechnology
SizeLarge
Full Stock Analysis →
Lexicon Pharmaceuticals
NAQ:LXRX
28
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Kestra Medical Technologies
NSQ:KMTS
21
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Karyopharm Therapeutics
NSQ:KPTI
6
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →